Clinical Evaluation of the PowerGlide™ Pro Midline Catheter
NCT ID: NCT06037525
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2018-01-01
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Midline Programme - Vascular Nursing Team
NCT03871010
Midlines and Thrombophlebitis
NCT03725293
Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions
NCT01246505
Prospective Observational Study of the Power PICC Family of Devices and Accessories
NCT04263649
Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes
NCT06365528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PowerGlide™ Pro Midline Catheter
Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* poor peripheral vein status
* Administration of alprostadil
Exclusion Criteria
* allergy to catheter material
* minor age
* life threatening conditions
* requirement for central venous catheter
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Augsburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Hyhlik-Duerr, PhD
Role: STUDY_DIRECTOR
University Hospital Augsburg Vascular Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Augsburg
Augsburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIDLINE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.